Loading company…
PerioTrap develops a small-molecule treatment for periodontitis.
Founded in 2018 and based in Halle, Germany, PerioTrap Pharmaceuticals develops a small-molecule treatment for periodontitis. The treatment targets disease-causing bacteria while aiming to preserve commensal bacteria.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in